Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets

Author(s):  Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D

Issue:  May/Jun 2003 - Diabetes and Wound Care
View All Articles in Issue

Abstract:  The qualification and quantification of dapsone in suspension were developed and shown to be stability indicating by means of a reverse-phase high-performance liquid chromatographic method. The real solubility of dapsone in water was calculated to be 0.208 mg/mL at 25°C. The enthalpy of solution and the entropy of solution were calculated to be -175.6 J/g and -43605.7 J/K/M, respectively. An extemporaneous suspension was formulated from commercially available dapsone tablets, and the chemical stability of dapsone in the suspension was determined by means of accelerated stability testing. The 91-day analytical stability testing study was conducted at 4, 30, 50, 60, and 70°C. The energy of activation for the suspension was determined to be –23288.35 J/K/M. The zero-order rate of degradation for dapsone (k0,25) in suspension at 25°C was found to be 0.040845 day-1. The first-order rate of degradation for dapsone in solution was found to be 0.196370 (mg/mL)(day-1). The shelf life for the suspension was calculated to be 31.67 days at 25°C and 230.76 days under refrigeration at 4°C.

Related Keywords: Dapsone tablets, formulation development of extemporaneous suspension prepared from, Dapsone tablets, stability testing of extemporaneous suspension prepared from

Related Categories: PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Kaila Nitin, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D May/Jun 2003 233-239 Buy
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Alexander Kenneth S, Thyangarajapuram N Sep/Oct 2003 389-393 Buy
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets Zaid Abdel Naser, Assali Mohyeddin, Qaddomi Aiman, Ghanem Mashhour, Zaaror Yara Abu Mar/Apr 2014 169-174 Buy
Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets Zaid Abdel Naser, Malkieh Numan, Kharoaf Maher, Ghoush Abeer Abu, Al-Ramahi Rowa' Jul/Aug 2012 342-346 Buy
Stability of Allopurinol Suspension Compounded from Tablets Alexander Kenneth S, Davar Nipun, Parker Gordon A Mar/Apr 1997 128-131 Buy
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Alexander Kenneth S, Kaushik Sarita Mar/Apr 2004 147-152 Buy
Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets Gupta Vishnu D Nov/Dec 2001 480-481 Buy
Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations Sidhom Madiha B, Rivera Nadya, Almoazen Hassan, Taft David R, Kirschenbaum Harold L Sep/Oct 2005 402-406 Buy
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Schotik Debora Jan/Feb 2001 9 Buy
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping Tong Henry H Y, Chan Hokman, Du Zhen, Zheng Ying Jul/Aug 2010 342-345 Buy